Arch Pharmalabs

Arch Pharmalabs setup four manufacturing facility; plans overseas acquisitions

The company contract bulk drug manufacturer, Arch Pharmalabs has established four manufacturing plants at Gurgaon at an investment of Rs 50 crore to manufacture active pharmaceutical ingredients (APIs) targeted at the regulated US and European markets.

Malvinder Mohan Singh, CEO & MD, Ranbaxy has inaugurated the facility named as ‘Project Paschim’.